Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. by Vassiliadis, S et al.
Serum levels of pro- and
anti-inflammatory cytokines in
non-pregnant women, during
pregnancy, labour and abortion
S. Vassiliadis,
1,3,CA A. Ranella,
1 L. Papadimitriou,
1
A. Makrygiannakis
2 and I. Athanassakis
1
1Department of Biology, and 
2Department of
Medicine, Division of Gynaecology, University of
Crete, Heraklion, and 
3Immunology Centre for
Pregnancy, Heraklion, Crete, Greece
CACorresponding Author
Tel: (+30) 081 394 355
Fax: (+30) 081 243 656
Email: simon@biology.uch.gr
DISTURBANCE of  the  cytokine  equilibrium  has  been
accused  for many  pathological  disorders.  Microbial
infections, autoimmune diseases, graft rejection have
been  correlated  to  over-  or  under-production  of
specific cytokines which are produced as responder
molecules  to  the  various  immune  stimuli.  The  sole
naturally occurring immune reaction in the organism
is  developed  during  the  gestational  period  where,
despite the presence of a semi-allogeneic graft, mater-
nal  immunoreactivity  is  driven  to  support  fetal
growth.  The  successful  embryo  development  has
been  attributed  to  the  important  intervention  of
cytokines  where  some  have  been  characterized  as
indispensable and others deleterious to fetal growth.
However,  the  physiological  levels  of  many  factors
during the gestational process have not been deter-
mined. Thus, in the present study we have measured
and established the values of IL-1a , IL-2, IL-3, IL-4, IL-
6,  IL-10,  IL-12,  GM-CSF,  TNF-a and  IFN-g during  all
phases of human pregnancy (first, second and third
trimester of pregnancy, labour, abortions of the first
trimester)  as  well  as  in  the  non-pregnant  control
state.  This  is  an  attempt  to  assess  serum  protein
concentrations and  present  the physiological levels
of these cytokines at certain time intervals providing
thus a diagnostic advantage in pregnancy cases where
the  mother  cannot  immunologically  support  the
fetus.  Exploitation  of  this  knowledge  and  further
research may be useful for therapeutic interventions
in the future.
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Introduction
Despite the unique ability of the immune system to
highly specific antigen recognition, its susceptibility
to cytokines allows these molecules to dominate all
kinds of immune reactions. These proteins, produced
in an autocrine or paracrine fashion, bind to specific
receptors  initiating  thus  a  cascade  of  reactions  on
different targets having beneficial or harmful effects
since their redundancy and/or pleiotropic nature may
account for all possible reactions. With T helper (Th)
lymphocytes being the major producers of cytokines,
it  is  believed  that  the  equilibrated  balance  of Th1
versus  Th2  cytokines  defines  the  welfare  of  the
organism.1,2 The immune system, in order to ensure
protection  from  microbial  infections,  autoimmune
reactions,  graft  rejection,  allergies,  etc.,  leans  the
balance  towards  one  or  the  other  family  of
cytokines.
Pregnancy  is  a  natural  example  of  an  immune
reaction occurring for a determined time period in
the  organism  which  opposes  the  rules  of  graft
rejection. The semi- or allogeneic fetal  components
growing  in  the  privileged  site  of  uterus,  not  only
escape maternal immune attack but are supported by
the maternal immune system. An important role in the
maintenance  of  pregnancy  is  played  by  cytokines,
where successful fetal outcome is correlated to the
production of Th2 cytokines and fetal rejection to Th1
cytokines. Although  the  protective  role  of  the Th2
cytokine IL-10 during mid-gestation,3 as well as the
harmful effects of Th1 cytokines IL-2,4 TNF-a 5–7 and
IFN-g 5,8 have  been  demonstrated  in  mice,  other
studies  show  that  each  cytokine  follows  a  specific
pattern of expression each day of pregnancy in mice.9
These  observations  indicate  that  despite  the  bene-
ficial or harmful effect of a cytokine during a specific
time course of the gestational cycle, a determined up-
or downregulation of these factors must be followed,
pattern  that  will  decide  for  the  successful  or  not
outcome of pregnancy. It becomes thus mandatory to
define  the  physiological  levels  of  cytokines  during
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nostic character for the outcome of pregnancy.
In  the  present  report,  we  examined  the  serum
levels of  10 cytokines during  the first, second and
third trimesters of pregnancy, before pregnancy and
labour and compared the values of physiological first
trimester of pregnancy with cases of fetal rejection.
Materials and Methods
Patients
After informed consent of all patients, we analysed
the  serum  of  15  non-pregnant-state  women,  the
serum  of  19,  17  and  18  first,  second  and  third
trimester  women  respectively,  the  serum  of  15
women  in  labour  and  19  women  who  underwent
spontaneous  abortion. All  sera,  isolated  from  5ml
peripheral blood, were provided by the Division of
Gynaecology of  the  University  Hospital (Heraklion,
Crete).
Reagents and cytokine determination
Cytokine  detection  in  the  serum  was  achieved  by
commercial kits purchased from Endogen (Cambridge,
MA, USA; IL-1a , IL-2, IL-4, IL-6, IL-10, GM-CSF , TNF-a ,
IFN-g ) and R&D systems (Oxfordshine, UK; IL-3, IL-
12).  Serum  cytokine  measurement  was  performed
using an ELISA method as specified by the suppliers at
test  and reference wavelengths  of 450 and 550nm
respectively. The results are expressed in ng/ml and
were compared with standard curves obtained from
titrations of the corresponding recombinant factors
provided by the suppliers. The Endogen ELISA kits for
IL-1a , IL-4, GM-CSF and IFN-g detect <2pg/ml of the
equivalent protein, whereas the IL-2 kit detects <6pg/
ml, IL-6 <1pg/ml, IL-10 <3pg/ml and TNF-a <5pg/ml.
The R&D Systems ELISA kits for IL-3 and IL-12 detect
7.4 and 5pg/ml of protein respectively. In all cases the
above values given for the lower limit of detection is
the smallest dose of protein that is not zero with 95%
confidence. Both manufacturers guarantee the speci-
ficity of each individual kit.
Statistical analysis
Since the abortions studied occurred during the first
trimester  of  pregnancy,  the  Student’s  t-test  was
employed in order to compare the significance levels
(P)  between  the  abortion  values  of  the  different
cytokines and those of  the actual  first  trimester  of
gestation.  In  this  particular  group  of  analysis  all  P
values equal or lower than 0.025 are considered to be
non-significant. Degrees of freedom: 18 (n–1).
Results and Discussion
Cytokine  levels  in  the  serum  seem  to  reflect  the
pathologic state of the organism and may, in many
cases, have a prognostic character for therapy sub-
scription. In this study, concentrating our interest to
human pregnancy where the rates of fetal rejection
dangerously  increase,  we  define  the  physiological
levels  of  10  different  cytokines  before,  during  and
after pregnancy.
Assessment of cytokine levels during
pregnancy and in the non-pregnant state
The goal of this work was to determine the actual
(physiological)  levels  of  diverse  cytokines  during
pregnancy. For this, serum from non-pregnant women
as well as during the first, second and third trimester
of pregnancy and labour was collected and analysed
by  ELISA  as  to  the  cytokine  content.  In  addition,
serum from women who underwent abortion during
the  first  trimester  of  their  pregnancy  was  also
examined  and  the  same  cytokines  were  evaluated.
Table 1 thus presents the physiological values of the
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Table 1. Physiological cytokine values in human non-pregnant and pregnant state
Cytokine Cytokine levels (ng/ml±SEM) during the following states
Non-pregnant
state
1st trimester 2nd trimester 3rd trimester Labour
IL-1a 1.76 ± 0.40 1.73 ± 0.53 1.55 ± 0.34 1.89 ± 0.42 1.76 ± 0.70
IL-2 3.60 ± 0.30 3.63 ± 0.60 3.56 ± 0.46 3.41 ± 0.61 3.23 ± 0.96
IL-3 3.80 ± 0.40 3.85 ± 0.52 3.36 ± 0.54 3.32 ± 0.55 3.60 ± 0.46
IL-4 0.16 ± 0.01 0.14 ± 0.02 0.16 ± 0.05 0.17 ± 0.04 0.15 ± 0.01
IL-6 2.70 ± 0.30 2.55 ± 0.24 2.91 ± 0.38 2.91 ± 0.34 2.87 ± 0.31
IL-10 0.77 ± 0.02 0.76 ± 0.07 0.74 ± 0.09 0.88 ± 0.10 0.96 ± 0.11
IL-12 0.83 ± 0.11 0.79 ± 0.10 0.85 ± 0.27 0.80 ± 0.08 0.73 ± 0.03
GM-CSF 2.70 ± 0.25 2.78 ± 0.28 3.01 ± 0.32 3.14 ± 0.73 3.52 ± 0.57
TNF-a 0.62 ± 0.04 0.60 ± 0.06 0.57 ± 0.09 0.60 ± 0.07 0.62 ± 0.03
IFN-g 1.07 ± 0.14 1.06 ± 0.08 1.14 ± 0.11 1.33 ± 0.14 1.35 ± 0.20
n 15 19 17 18 15cytokines studied. In the course of this analysis we
detected  statistically  significant  (P <  0.05  to  P <
0.001)  differences  between  the  non-pregnant  state
and pregnancy for IL-1a (drop in second trimester by
13%), IL-2 (decrease mainly at labour  by 11%), IL-3
(decrease at second and third trimester by 14%), IL-10
(increase at labour by 28%), GM-CSF (increase at third
trimester and labour  by 16%  and 30% respectively)
and IFN-g (increase at third trimester and labour by
25% and 26% respectively).
By the same token, significant differences within
the different pregnancy stages are obtained by IL-1a
(minimal  production in  the  second trimester),  IL-2
(decrease  in  third  trimester  and  labour),  IL-3
(decrease after the first trimester), IL-6 (increase after
the  first  trimester),  IL-10  (increase  during  labour),
GM-CSF  and  IFN-g (steady  increase  after  the  first
trimester).
TNF-a , accused for pregnancy failure,5–7 presents a
stable production profile in all stages. The same is also
shown for IL-12, a factor that has been reported as an
immunomodulator  in  various  mechanisms  during
pregnancy.10–12 Finally,  IL-10  and  IL-4,  named  as
protective agents during pregnancy,3,13 show a con-
stant presence at the first two trimesters with IL-10
showing a peak of production during labour (as stated
above). These four cytokines show a minimal pres-
ence  in  the  serum  of  pregnant  or  non-pregnant
women  at  levels  ranging  from  0.88  to  0.14ng/ml,
implying  a  possible  maintenance  role  during  the
gestation period.
Assessment of cytokine levels in the first
trimester abortions
The serum  from women who  aborted during their
first  trimester  was  also  examined  for  the  same
cytokine  content  and  the  corresponding  values
were determined. Table 2 shows not only the cyto-
kine values of aborted women but also a statistical
comparison  with  the  actual  values  (taken  from
Table  1)  of  women  in  their  first  trimester  of  con-
tinuing  pregnancy.  It  is shown  that  although  there
are  no  differences  for  IL-4,  IL-12  and  TNF-a (we
consider  P £  0.025  as  not  significant,  as  stated in
the  Methods),  the  situation  with  the  remaining
cytokines  is  totally  different. Whilst  only  the  IL-1a
and  IL-3  levels  drop  during  abortion  (IL-1a not
significantly by 8% or P < 0.3 but with a consider-
able 17%  decrease in IL-3), on the contrary, IL-2, IL-
6,  IL-10,  GM-CSF  and  IFN-g levels  increase  when
abortion  occurs with  IFN-g being  more  obvious in
magnitude  (53%   of  increase).  Although  it  is  not
clear  yet  whether  increase  in  cytokine  production
is responsible  for the  abortion  process  or it  is the
abortion  itself  that  modulates  cytokine  levels,  this
latter  observation  gives  an  insight  to  and supports
the Th1 versus Th2 situation in pregnancy. It is seen
here that Th1 cytokine levels are augmented during
abortion whereas, Th2 are not significantly different
or dropping. Another point that  merits attention is
the  IFN-g increased  levels  during  abortion.  This
piece  of  data  confirms  previous  reports  and
strengthens the correlation between this agent and
fetal rejection.7
The results presented here do not differ from the
recently published report by Tranchot-Diallo et al.14
where modulation of cytokine gene expression (TNF-
a , IFN-g , GM-CSF , IL-1b , IL-2, IL-4, IL-6 and IL-10) by
RT -PCR in pregnancy was evaluated.
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